openPR Logo
Press release

Opioid Induced Constipation Market Size, Share, Price, Trends, Growth, Analysis, Report and Forecast 2024-2032

02-08-2024 06:23 AM CET | Health & Medicine

Press release from: Expert Market Research

Opioid Induced Constipation Market

Opioid Induced Constipation Market

The global opioid induced constipation market size is anticipated to grow at a CAGR of 7.2% during the forecast period of 2024-2032, driven by the rising prevalence of diseases and introduction of peripheral opioid receptor antagonists (PORAs).

Opioid Induced Constipation: Introduction

Opioid-induced constipation (OIC) is a common side effect of opioid medications, characterized by difficulty or infrequency in bowel movements. Opioids, commonly prescribed for pain management, can slow down the digestive system, leading to hard and dry stools, abdominal discomfort, and a sense of incomplete evacuation. OIC significantly impacts the quality of life for individuals using opioids, necessitating proactive management strategies such as lifestyle modifications, increased fluid intake, and specific medications designed to alleviate constipation without compromising pain relief.

Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/opioid-induced-constipation-market/requestsample

Key Trends in the Opioid Induced Constipation Market

Pharmaceutical companies are focusing on developing targeted medications specifically designed to alleviate OIC, offering more effective and efficient relief for patients. There is a growing emphasis on raising awareness among healthcare professionals and patients about the risks of OIC associated with opioid use, promoting proactive management and preventive measures.

The emergence of PORAs, such as naloxegol and naloxone, as a therapeutic class addresses OIC by blocking opioid receptors in the gastrointestinal tract, mitigating constipation while preserving pain relief. Healthcare providers are adopting a patient-centric approach to OIC management, considering individual patient needs and preferences to tailor treatment plans for optimal outcomes.

Lifestyle modifications, dietary changes, and increased physical activity are increasingly integrated into OIC management strategies, offering a holistic approach to alleviate symptoms. The use of telemedicine and remote monitoring technologies allows healthcare professionals to monitor and manage OIC in real-time, providing timely interventions and support to patients.

Collaborative efforts and global health initiatives aim to standardize OIC management practices, particularly in regions where opioid use is prevalent, ensuring consistent and effective care. Ongoing research explores novel mechanisms to address OIC, including the exploration of new drug targets and innovative therapeutic approaches that minimize constipation while preserving the pain-relieving effects of opioids.

The market is witnessing the introduction of biosimilars and generic formulations of OIC medications, increasing accessibility and affordability for patients. Regulatory agencies are actively involved in updating guidelines and expediting the approval of novel OIC therapies, streamlining the path to market for innovative treatments.

Collaborations between pharmaceutical companies, healthcare organizations, and research institutions are fostering innovation and accelerating the development of new OIC management solutions.

Read Full Report with Table of Contents - https://www.expertmarketresearch.com/reports/opioid-induced-constipation-market

Opioid Induced Constipation Market Segmentation

Market Breakup by Product

• Mu-opioid Receptor Antagonists
• Chloride Channel-2 Activators
• Others

Market Breakup by Prescription Type

• Over the Counter
• Prescription

Market Breakup by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Opioid Induced Constipation Market Overview

In North America, the United States and Canada have a substantial OIC market with high opioid prescription rates. Awareness campaigns and advanced healthcare infrastructure contribute to proactive OIC management.

In Europe, including the United Kingdom, Germany, and France, the OIC market is growing, influenced by varying opioid use patterns and increasing awareness among healthcare professionals and patients.

In the Asia-Pacific region, countries like China, Japan, and India show an evolving OIC market, impacted by opioid prescription practices, healthcare infrastructures, and ongoing efforts to address opioid-related issues.
Latin America, represented by Brazil and Mexico, is an emerging market for OIC management, with OIC prevalence and treatment accessibility influenced by opioid adoption and collaborations with global pharmaceutical companies.

In the Middle East and Africa, healthcare systems are evolving, and variations in opioid use and OIC awareness influence treatment accessibility. International collaborations contribute to advancing OIC management in these regions.

Opioid Induced Constipation Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Mylan N.V.
• Fresenius Kabi AG
• Hikma Pharmaceuticals PLC
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Bristol Myers Squibb Company
• GSK Plc.
• Bayer AG
• Aurobindo Pharma
• S.L.A. Pharma AG
• Salix Pharmaceuticals
• Takeda Pharmaceutical Company Limited

Read More Reports

Pharmacovigilance Market - https://www.expertmarketresearch.com/reports/pharmacovigilance-market

Ophthalmic Devices Market - https://www.expertmarketresearch.com/reports/ophthalmic-devices-market

Peptide Therapeutics Market - https://www.expertmarketresearch.com/reports/peptide-therapeutics-market

Pharmacovigilance Market - https://www.expertmarketresearch.com/reports/pharmacovigilance-market

Surgical Instrument Tracking Systems Market - https://www.expertmarketresearch.com/reports/surgical-instrument-tracking-systems-market

Media Contact:

Company Name: Claight Corporation
Contact Person: Jhon Roy, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Induced Constipation Market Size, Share, Price, Trends, Growth, Analysis, Report and Forecast 2024-2032 here

News-ID: 3376712 • Views:

More Releases from Expert Market Research

Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and
Global Fruit Juice Market Size, Report and Forecast 2025-2034
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions. The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy. Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial
Why will smart pulse oximeters market hit $3.50Bn by 2034?
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the

All 5 Releases


More Releases for OIC

Opioid-Induced Constipation (OIC) Drug Market Will Generate Record Revenue by 20 …
Opioid-Induced Constipation (OIC) Drug Market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market growth includes rising number of geriatric patients as these patients use opioid analgesics such as morphine, hydromorphone, codeine, etc. as a prescription for chronic non-cancer pain which has severe adverse effects on the digestive system resulting in huge demand for OIC drugs. For
Targeted Treatment Options For Opioid-Induced Constipation (OIC) In Global Marke …
Opioids are prescription drugs taken for treatment of chronic pain. While they relieve the pain, they can give opioid-induced constipation. The adverse effects associated with the opioids are decreasing gastrointestinal tract’s motility, making patient’s strain, and making of solid discharges. Adults are most likely to prone to opioid-induced constipation owing to less immobility, poor diet, and fluid intake. The opioid-induced constipation treatment market is growing at a significant rate owing
Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018 - Research By Marke …
Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018, provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline landscape. Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Opioid-Induced Constipation (OIC) (Toxicology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its
Opioid-Induced Constipation (OIC) - Complete Analysis on Therapeutics by Stage o …
A new research document is added in HTF MI database of 64 pages, latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2018, provides an overview of the Opioid-Induced Constipation (OIC) (Toxicology) pipeline landscape. Opioids are effective pain relievers, but often have the side effect of constipation. These medicines affect the gastrointestinal tract in a variety of ways. Opioids increase the amount of time it takes
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2017, provides an overview of the Opioid-Induced Constipation (OIC) (Oncology) pipeline landscape. Opioids are effective pain relievers, but often have the side effect of constipation. These medicines affect
Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2016
Global Markets Directs, Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2016, provides an overview of the Opioid-Induced Constipation (OIC) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Opioid-Induced Constipation (OIC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development